Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • November 2022
  • Case
  • HBS Case Collection

Ajax Health: A New Model for Medical Technology Innovation

By: Regina E. Herzlinger and Ben Creo
  • Format:Print
  • | Language:English
  • | Pages:27
ShareBar

Abstract

This case teaches key success factors for both startups and established medtech firms. It examines how to structure a firm to maximize financial returns. Medtech entrepreneur Duke Rohlen is proposing a new model for innovation and business growth. From 2007 to 2019, Rohlen sold four medical technology (medtech) companies, all of which were acquired at significant multiples of the capital invested. While the average medtech startup exited 8.6 years after starting, Rohlen’s companies had an average time to exit of 40 months. Rohlen then saw that the companies acquiring his startups were sold to larger firms, in short time spans after the initial sale, at prices significantly higher than their pre-acquisition value. Rohlen observed how much value his companies had created for others after he sold them: $1.5 billion for Covidien (after sale of FoxHollow to ev3), $1.1 billion for Philips (after sale of CVI’s Stellarex from Covidien to Spectranetics), and $280 million for Stryker (after sale of Spirox to Entellus), for a total of about $2.9 billion. Rohlen wondered how he could still create innovative new products yet capture a higher portion of the financial returns. He proposed a new model for innovation and business growth, called the Chassis and Growth Drivers model.
Partnering with major private equity firms Hellman & Friedman and Kohlberg Kravis Roberts & Company (KKR), Rohlen's firm Ajax Health plans to invest $1.3 billion to prove the model's viability. For $1 billion, they're submitting a bid to buy Cordis, a maker of medical devices for cardiovascular and endovascular procedures. Cordis was formerly a standalone business before it was bought by Johnson & Johnson and then its current owner and seller, Cardinal Health. If their bid is successful, they will invest an additional $300 million to fund an off-balance sheet accelerator, which will develop innovative new products that will drive revenue growth for Cordis. Should Rohlen and his partners invest the $1.3 billion to implement this model, and why or why not? Was Cordis the right opportunity for Rohlen and his team?
This case is suitable both as a general business case for MBA students of any level and as a case for courses focused on the healthcare industry, entrepreneurship, and private equity. Ajax Health is headquartered in California, and Cordis is a worldwide company with headquarters in Florida. Rohlen's previous startups included FoxHollow Technologies, CV Ingenuity, Spirox, and EPIX Therapeutics.

Keywords

Business Startups; Success; Innovation Strategy; Mergers and Acquisitions; Market Entry and Exit; Financial Strategy; Business Model; Partners and Partnerships; Entrepreneurship; Private Equity; Technology Industry; Medical Devices and Supplies Industry

Citation

Herzlinger, Regina E., and Ben Creo. "Ajax Health: A New Model for Medical Technology Innovation." Harvard Business School Case 323-043, November 2022.
  • Educators

About The Author

Regina E. Herzlinger

General Management
→More Publications

More from the Authors

    • February 2023
    • JAMA Health Forum

    Maintaining Health Care Innovations After the Pandemic

    By: Regina E. Herzlinger, Barak D. Richman and Kevin A. Schulman
    • January 2023
    • Faculty Research

    Identify the Health Care Venture

    By: Regina E. Herzlinger and James Wallace
    • January 2023
    • Faculty Research

    Identify the Health Care Venture

    By: Regina E. Herzlinger and James Wallace
More from the Authors
  • Maintaining Health Care Innovations After the Pandemic By: Regina E. Herzlinger, Barak D. Richman and Kevin A. Schulman
  • Identify the Health Care Venture By: Regina E. Herzlinger and James Wallace
  • Identify the Health Care Venture By: Regina E. Herzlinger and James Wallace
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College